Effects Of Finerenone - A Novel Non-steroidal Mineralocorticoid Receptor Antagonist In A Model Of Pressure Overload-induced Cardiac Hypertrophy

被引：0
|
作者：
Grune, Jana
Benz, Verena
Brix, Sarah
Ban, Zsofia
Salatzki, Janek
Hoeft, Beata
Foryst-Ludwig, Anna
Klopfleisch, Robert
Kolkhof, Peter
Kintscher, Ulrich
机构：
来源：
HYPERTENSION | 2014年 / 64卷
关键词：
hypertrophy; cardioprotective drugs;
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
007
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [21] Puerarin attenuates pressure overload-induced cardiac hypertrophy
    Yuan, Yuan
    Zong, Jing
    Zhou, Heng
    Bian, Zhou-Yan
    Deng, Wei
    Dai, Jia
    Gan, Hua-Wen
    Yang, Zheng
    Li, Hongliang
    Tang, Qi-Zhu
    JOURNAL OF CARDIOLOGY, 2014, 63 (1-2) : 73 - 81
  • [22] Evodiamine attenuates pressure overload-induced cardiac hypertrophy
    Li, Fangfang
    Yuan, Yuan
    Zhang, Ning
    Wu, Qingqing
    Li, Jin
    Zhou, Mengqiao
    Yang, Zheng
    Tang, Qizhu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 10202 - 10213
  • [23] Apigenin inhibits pressure overload-induced cardiac hypertrophy
    Dong, Xuan
    Zhou, Heng
    Zhang, Yan
    Xu, Man
    Hao, Yarong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2018, 11 (04): : 3772 - 3778
  • [24] Naringenin attenuates pressure overload-induced cardiac hypertrophy
    Zhang, Ning
    Yang, Zheng
    Yuan, Yuan
    Li, Fangfang
    Liu, Yuan
    Ma, Zhenguo
    Liao, Haihan
    Bian, Zhouyan
    Zhang, Yao
    Zhou, Heng
    Deng, Wei
    Zhou, Mengqiao
    Tang, Qizhu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2015, 10 (06) : 2206 - 2212
  • [25] SUPPRESSION OF MOUSE CRESCENTIC GLOMERULONEPHRITIS WITH A NON-STEROIDAL MINERALOCORTICOID RECEPTOR ANTAGONIST
    Tesch, G. H.
    Han, Y.
    Ma, F.
    Nikolic-Paterson, D. J.
    Kolkhof, P.
    NEPHROLOGY, 2015, 20 : 33 - 34
  • [26] Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction
    Lima-Posada, Ixchel
    Stephan, Yohan
    Soulie, Matthieu
    Palacios-Ramirez, Roberto
    Bonnard, Benjamin
    Nicol, Lionel
    Kolkhof, Peter
    Jaisser, Frederic
    Mulder, Paul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [27] Finerenone: Questions and Answers-The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist
    Di Lullo, Luca
    Lavalle, Carlo
    Scatena, Alessia
    Mariani, Marco Valerio
    Ronco, Claudio
    Bellasi, Antonio
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (12)
  • [28] Differential Effects of Myocardial Afadin on Pressure Overload-Induced Compensated Cardiac Hypertrophy
    Zankov, Dimitar P.
    Sato, Akira
    Shimizu, Akio
    Ogita, Hisakazu
    CIRCULATION JOURNAL, 2017, 81 (12) : 1862 - +
  • [29] Rac1-Mediated Activation of Mineralocorticoid Receptor in Pressure Overload-Induced Cardiac Injury
    Ayuzawa, Nobuhiro
    Nagase, Miki
    Ueda, Kohei
    Nishimoto, Mitsuhiro
    Kawarazaki, Wakako
    Marumo, Takeshi
    Aiba, Atsu
    Sakurai, Takayuki
    Shindo, Takayuki
    Fujita, Toshiro
    HYPERTENSION, 2016, 67 (01) : 99 - 106
  • [30] Role of the V1 vasopressin receptor in pressure overload-induced cardiac hypertrophy
    Crandall, David L.
    Kasparcova, Viera
    Semus, Hillary M.
    Vlasuk, George P.
    Bueno, Orlando P.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2007, 42 : S32 - S32
12345